ArnabBasuMDMPH

PubMed

• 35 citations
  Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study.
  Vadim S Koshkin, Nicholas Henderson, Marihella James, Divya Natesan, Dory Freeman
  Cancer. 2022-03-15
• 22 citations
  Association of PD-L1, PD-L2, and Immune Response Markers in Matched Renal Clear Cell Carcinoma Primary and Metastatic Tissue Specimens.
  Arnab Basu, Jennifer H. Yearley, Lakshmanan Annamalai, Christopher Pryzbycin, Brian I. Rini
  American Journal of Clinical Pathology. 2019-01-07
• 2 citations
  Renal cell carcinoma histologic subtypes exhibit distinct transcriptional profiles.
  Pedro Barata, Shuchi Gulati, Andrew Elliott, Hans J Hammers, Earle Burgess
  The Journal of Clinical Investigation. 2024-04-23

Journal Articles

• Association of PD-L1, PD-L2, and Immune Response Markers in Matched Renal Clear Cell Carcinoma Primary and Metastatic Tissue Specimens  
  Arnab Basu, MD, American Journal of Clinical Pathology
• “Palliative care in low and medium resource countries  
  Basu A, Mittag-Leffler N, Miller K, Cancer Journal, 9/2013

Books/Book Chapters

• Global Perspectives on Cancer: Incidence, Care, and Experience 
  Chapter: Palliative Care for Oncology Patients in the 21st Century: A Global Perspective 
  Kenneth MillerEditors: Kenneth Miller.ABC-CLIO Press 2015

Abstracts/Posters

• “Platelet Activation Markers and Aggregation in Patients with Advanced Adenocarcinoma undergoing Chemotherapy: Correlation with Khorana Scores
  Basu A., Gosain R., Tantry U, Miller K, Gurbel. P, European Cancer Congress, Vienna, Austria, 9/2015
• Oncologists' perception of residual cancer recurrence risk and recommended follow-up care
  Basu A., Gosain R., Opneja A., Miller K, J Clin Oncol 2015 (suppl; e22003), ASCO - 2015, 6/2015
• A Correlative Study of Platelet Aggregation with Chemotherapy Associated Thrombosis
  Basu A., Gosain R., Tantry U, Miller K, ACP - Maryland State Meeting, Baltimore, Maryland, 5/14/2015
• Platelet reactivity in advanced adenocarcinoma patients and healthy controls
  Basu A., Gosain R., Tantry U , Miller K, J Clin Oncol 2015 (suppl; e20619), ASCO - 2015, 5/5/2015
• “ A case report of unicentric plasma cell variant castleman disease in the absence of HIV and HHV8
  Basu A, Banavali A, Miller, American Thoracic Society Meeting, Denver, Colorado, 5/2015
• a case of recalcitrant sarcoma – is personalized targeted therapy the answer?
  Basu A, Park H, Subbiah V, American Medical Association - Research Symposium, Dallas, Texas, 11/2014
• Levamisole induced skin necrosis syndrome: A case report
  Basu A, Singh A, Gradon J:, Maryland ACP Meeting, Baltimore, Maryland, 5/2014
• “A decade of incubation : Malignant transformation of an iliac crest amyloidoma”
  Singh A, Basu A, Miller, National ACP Conference, Orlando Florida, 4/2014
• Total Lymphocyte count and lymphocyte morphology as a monitoring tool for HIV infected patients in resource limited settings
  Basu A, Gupta S, Guha S, International Conference on Opportunistic Pathogens in AIDS, All India Institute of Medical Sciences , Delhi, India, 2008
• Join now to see all